Literature DB >> 9466932

The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.

S Hansen1, D P Lane, C A Midgley.   

Abstract

The contribution of each of the structural domains of p53 to its function has been discussed widely in the literature. Crystallographic studies have revealed much about the structure of the core DNA binding domain, but as it has not been possible to use this approach for the intact protein, the effect of the domains flanking the core must be investigated by more indirect techniques. In this study a series of truncated murine p53 proteins has been investigated for DNA binding activity at 4 degrees C and 37 degrees C, transcriptional activation, and tumour suppression activity. Full-length p53, and truncations lacking the N terminus, purified from a baculovirus expression system all show latency for DNA binding; that is, they must be activated to bind by association with a C-terminal antibody such as PAb421. This demonstrates that latency for DNA binding is independent of the N terminus. Truncations lacking the C-terminal oligomerisation domain, and the isolated core domain, can only be activated to bind DNA and PAb1620 (an antibody recognising the wild-type conformation of the core domain) in the presence of cross-linking antibodies, while murine core only binds to DNA in the presence of PAb1620. An analysis of the thermostability of DNA binding revealed that antibodies that bind the N terminus of p53 could protect the protein against loss of activity at 37 degrees C. C-terminal antibodies, however, were ineffective unless the N-terminal 37 amino acid residues were absent. The N terminus may retain some secondary structure, since it is the main contributor to the anomalous migration in SDS-polyacrylamide gels. Our results suggest that the N terminus has a destabilising effect that influences conformation of p53 at 37 degrees C, so cellular proteins binding to the N terminus in vivo may modulate p53 conformation and stability. The effects on thermostability are also direct evidence showing that antibodies binding to N-terminal deletions create a conformational change in the rest of the molecule. In addition, longer deletions of the C terminus reduce the ability of p53 to transactivate target genes and inactivate tumour suppression activity, while truncations of the N terminus retain partial tumour suppression activity. Our results clearly show participation of both the N and C termini in the regulation of all the functions of p53 at 37 degrees C, indicating that distinct, independent domains interact with each other within, the flexible structure of p53.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466932     DOI: 10.1006/jmbi.1997.1507

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.

Authors:  M Gaitanou; P Buanne; C Pappa; N Georgopoulou; A Mamalaki; F Tirone; R Matsas
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.

Authors:  Shih-Shun Chen; Pi-Chu Chang; Yu-Wen Cheng; Fen-Mei Tang; Young-Sun Lin
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

3.  The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.

Authors:  Andrei L Okorokov; Michael B Sherman; Celia Plisson; Vera Grinkevich; Kristmundur Sigmundsson; Galina Selivanova; Jo Milner; Elena V Orlova
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

4.  Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.

Authors:  Fan He; Wade Borcherds; Tanjing Song; Xi Wei; Mousumi Das; Lihong Chen; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

5.  Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.

Authors:  Alexander S Krois; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

6.  Physical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic protein.

Authors:  Yanjie Chen; Takayuki Fujita; Di Zhang; Hung Doan; Decha Pinkaew; Zhihe Liu; Jiaxin Wu; Yuichi Koide; Andrew Chiu; Curtis Chen-Jen Lin; Jui-Yoa Chang; Ke-He Ruan; Ken Fujise
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 7.  Strategies for manipulating the p53 pathway in the treatment of human cancer.

Authors:  T R Hupp; D P Lane; K L Ball
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

8.  p53 Amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype.

Authors:  Anuj Kumar Sharma; Amjad Ali; Rajan Gogna; Amir Kumar Singh; Uttam Pati
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

9.  Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability.

Authors:  P V Nikolova; J Henckel; D P Lane; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.